Curative treatment of Stage i non-small-cell lung cancer in patients with severe COPD: Stereotactic radiotherapy outcomes and systematic review

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1149-1156

  Palma, David ^a,b   Lagerwaard, Frank ^a   Rodrigues, George ^b   Haasbeek, Cornelis ^a   Senan, Suresh ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Chronic obstructive pulmonary disease; Non small cell lung cancer; Stereotactic body radiation therapy; Surgery

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; GOLD COMPOUNDS; RADIOTHERAPY; SURGERY;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; FORCED EXPIRATORY VOLUME IN 1; LOCOREGIONAL CONTROL; NON SMALL CELL LUNG CANCER; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC BODY RADIOTHERAPY; STEREOTACTIC RADIOTHERAPY;

PULMONARY DISEASES;

CANCER CONTROL; CANCER STAGING; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART ARRHYTHMIA; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL LITERATURE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84856376628     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.005     Document Type: Article

References (40)

1. R.S. Loganathan, D.E. Stover, and W. Shi Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer Chest 129 2006 1305 1312
2. K. Kishi, J.W. Gurney, and D.R. Schroeder The correlation of emphysema or airway obstruction with the risk of lung cancer: A matched case-controlled study Eur Resp J 19 2002 1093 1098
3. S.S. Islam, and D. Schottenfeld Declining FEV1 and chronic productive cough in cigarette smokers: A 25-year prospective study of lung cancer incidence in Tecumseh, Michigan Cancer Epidemiol Biomark Prevent 3 1994 289 298
4. D.M. Mannino, A.S. Buist, and T.L. Petty Lung function and mortality in the United States: Data from the First National Health and Nutrition Examination Survey follow up study Thorax 58 2003 388 393
5. D.M. Mannino, D.E. Doherty, and B.A. Sonia Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study Respir Med 100 2006 115 122
6. J.B. Soriano, G.T. Visick, and H. Muellerova Patterns of comorbidities in newly diagnosed COPD and asthma in primary care Chest 128 2005 2099 2107
7. G.L. Colice, S. Shafazand, and J.P. Griffin Physiologic evaluation of the patient with lung cancer being considered for resectional surgery Chest 132 2007 161S 177S
8. A. Brunelli, A. Charloux, and C.T. Bolliger ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Eur Resp J 34 2009 17 41
9. X. Qiao, O. Tullgren, and I. Lax The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
10. A.E. Martin-Ucar, K.R. Fareed, and A. Nakas Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival? Thorax 62 2007 577 580
11. F.J. Lagerwaard, C.J.A. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
12. A.J. Fakiris, R.C. McGarry, C.T. Yiannoutsos, L. Papiez, M. Williams, M.A. Henderson, and R. Timmerman Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
13. C.W. Hurkmans, J.P. Cuijpers, and F.J. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: Report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
14. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://www.goldcopd.org. Accessed Jan. 10, 2010.
15. F.J. Lagerwaard, C.J.A. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
16. W.F. Verbakel, S. Senan, and J.P. Cuijpers Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs Radiother Oncol 93 2009 122 124
17. D. Palma, S. Senan, and C.J.A. Haasbeek Radiological and clinical pneumonitis after stereotactic lung radiotherapy: A matched analysis of 3D-conformal and volumetric modulated arc therapy techniques Int J Radiat Oncol Biol Phys 2010 Jun 26 [Epub ahead of print]
18. Clinical Toxicity Criteria for Adverse Events, version 3.0. https://webapps.ctep.nci.nih.gov/webobjs/ctc/webhelp/welcome-to-ctcae.htm. Accessed Jan. 10, 2010.
19. K.K. Lau, A.E. Martin-Ucar, and A. Nakas Lung cancer surgery in the breathless patient - the benefits of avoiding the gold standard Eur J Cardiothorac Surg 38 1 2010 Jul 6 13 Epub 2010 Mar 11
20. A.E. Martin-Ucar, A. Nakas, and J.E. Pilling A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients Eur J Cardiothorac Surg 27 2005 675 679
21. A.E. Martin-Ucar, K.R. Fareed, and A. Nakas Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival? Thorax 62 2007 577 580
22. T. Win, A. Jackson, and L. Sharples Relationship between pulmonary function and lung cancer surgical outcome Eur Resp J 25 2005 594 599
23. C.T. Bolliger, and A.P. Perruchoud Functional evaluation of the lung resection candidate Eur Resp J 11 1998 198 212
24. H. Shennib, J. Bogart, and J.E. Herndon Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study J Thorac Cardiovasc Surg 129 2005 813 818
25. C. Gebitekin, P.G. Martin, and C.M. Satur Results of pneumonectomy for cancer in patients with limited ventilatory function Eur J Cardiothorac Surg 9 1995 347 351
26. P. Magdeleinat, A. Seguin, and M. Alifano Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment Eur J Cardiothorac Surg 27 2005 1099 1105
27. M. Henderson, R. McGarry, and C. Yiannoutsos Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 404 409
28. K.L. Stephans, T. Djemil, and C.A. Reddy Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients J Thorac Oncol 4 2009 838 844
29. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
30. G.J. Herder, T.H. van, and R.P. Golding Clinical prediction model to characterize pulmonary nodules: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography Chest 128 2005 2490 2496
31. B.A. Whitson, S.S. Groth, and S.J. Duval Surgery for early-stage non-small cell lung cancer: A systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy Ann Thorac Surg 86 2008 2008 2016
32. National Emphysema Treatment Trial Research Group A Randomized Trial Comparing Lung-Volume-Reduction Surgery with Medical Therapy for Severe Emphysema New Engl J Med 22 348 2003 2059 2073
33. A.V. Louie, G. Rodrigues, M. Hannouf, G.S. Zaric, D.A. Palma, J.Q. Cao, B.P. Yaremko, R. Malthaner, and J.D. Mocanu Stereotactic Body Radiotherapy Versus Surgery for Medically Operable Stage I Non-Small-Cell Lung Cancer: A Markov Model-Based Decision Analysis Int J Radiat Oncol Biol Phys 2010 Oct 5 [Epub ahead of print]
34. H. van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial Lancet 359 2002 1388 1393
35. G.J.M. Herder, H. Kramer, and O.S. Hoekstra Traditional Versus Up-Front [18F] Fluorodeoxyglucose-Positron Emission Tomography Staging of Non-Small-Cell Lung Cancer: A Dutch Cooperative Randomized Study J Clin Oncol 24 2006 1800 1806
36. E.H. Belgers, J. Siebenga, and A.M. Bosch Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands Interact Cardiovasc Thorac Surg 10 2010 176 180
37. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 35 2010 Dec 10 5153 5159 Epub 2010 Nov 1
38. R.J. Cerfolio, and A.S. Bryant Survival of patients with true pathologic stage I non-small cell lung cancer Ann Thorac Surg 88 2009 917 923
39. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
40. M.A. Puhan, J. Garcia-Aymerich, and M. Frey Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: The updated BODE index and the ADO index Lancet 374 2009 704 711